BIOMAT Database Logo BIOMAT Database Logo

National gonorrhea therapy monitoring study: adverse drug reactions. 1976

H W Jaffe, and G H Reynolds, and P J Wiesner

The Center for Disease Control and cooperating clinics monitored adverse drug reactions in 6,969 patients who were treated for suspected uncomplicated gonorrhea with one of the four 1972 United States Public Health Service (USPHS) recommended regimens and returned for reexamination. Of those patients receiving the aqueous procaine penicillin G (APPG)-probenecid regimen, 2.0% had at least one adverse reaction and 0.18% experienced procaine reactions. No life-threatening reactions occurred. The overall reaction rates for the ampicillin-probenecid, tetracycline and spectinomycin regimens were 0.62%, 5.9%, and 0.61%, respectively. Our findings document the relative safety of the USPHS recommended regimens.

UI MeSH Term Description Entries
D008297 Male Males
D010402 Penicillin G Procaine Semisynthetic antibiotic prepared by combining penicillin G with PROCAINE. Benzylpenicillin Procaine,Jenacillin,Procaine Penicillin,G Procaine, Penicillin,Penicillin, Procaine,Procaine, Benzylpenicillin,Procaine, Penicillin G
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000198 Spectinomycin An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA. Actinospectacin,Adspec,Ferkel Spectam,Kempi,Prospec,Salmosan-T,Spectam,Spectinomycin Dihydrochloride, Anhydrous,Spectinomycin Dihydrochloride, Pentahydrate,Spectinomycin Hydrochloride,Stanilo,Trobicin,Salmosan T,Spectam, Ferkel
D013752 Tetracycline A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. 4-Epitetracycline,Achromycin,Achromycin V,Hostacyclin,Sustamycin,Tetrabid,Tetracycline Hydrochloride,Tetracycline Monohydrochloride,Topicycline,4 Epitetracycline
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

H W Jaffe, and G H Reynolds, and P J Wiesner
Monitoring adverse drug reactions.
May 1975, The Journal of the Royal College of General Practitioners,
H W Jaffe, and G H Reynolds, and P J Wiesner
Monitoring adverse drug reactions: a preliminary study.
August 1981, Canadian family physician Medecin de famille canadien,
H W Jaffe, and G H Reynolds, and P J Wiesner
Monitoring for adverse drug reactions.
April 2006, British journal of clinical pharmacology,
H W Jaffe, and G H Reynolds, and P J Wiesner
Drug monitoring and adverse reactions.
June 1977, British medical journal,
H W Jaffe, and G H Reynolds, and P J Wiesner
Computer monitoring of adverse drug reactions.
February 1978, Activitas nervosa superior,
H W Jaffe, and G H Reynolds, and P J Wiesner
Need for monitoring adverse drug reactions.
August 1998, The Journal of the Association of Physicians of India,
H W Jaffe, and G H Reynolds, and P J Wiesner
[Adverse drug reactions. Incidence and monitoring].
January 1979, Ugeskrift for laeger,
H W Jaffe, and G H Reynolds, and P J Wiesner
Clozapine deaths: monitoring adverse drug reactions.
February 2019, BMJ (Clinical research ed.),
H W Jaffe, and G H Reynolds, and P J Wiesner
Monitoring and managing adverse drug reactions.
February 1992, American pharmacy,
H W Jaffe, and G H Reynolds, and P J Wiesner
Drug therapy. 13. Adverse drug reactions.
June 1971, Northwest medicine,
Copied contents to your clipboard!